$BSX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:BSX after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 83.33%.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.22 USD
1.59 B USD
14.24 B USD
1.47 B
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
FIGI
BBG000C0LW92
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Morning Overview: Pullback and Anti Pattern's To Trade TodayThis morning I covered the overview of AMEX:SPY $AMEX:DIA. I talked about pattern recognition across markets, I gave valuable insight into potential pullbacks and anti patterns that are setting up. I provide entry ideas and mentioned the stocks that I like for trading today. Many of which were sho
BSX heads up at $86.01: Golden Genesis might end rocket trip3 charts show the same fibs in different tf's.
BSX has been a rocket ship for a while.
It has just hit a new Godlen Genesis fib.
The last one held it up for a few months.
It is POSSIBLE that we get a pullback here.
It is PROBABLE that we orbit this a few times.
It is PLAUSIBLE that we break and co
Boston Scientific - interesting formationBSX share price looks like it will go more to the upside. Especially after BSX reported its 1Q 2024 financial results and lifted up full year 2024 financial guidance.
Another positive trigger will occur end of May - June as the company should announced completion of the acquisition of Axonics (AXNX)
Confirmed cup and handle pattern on BSX chartHi,
please see the following chart pattern, that has been confirmed in the last weeks.
Accordingly to the rules of the pattern, the price target is about 70$.
If doesn't will come a market crash, there is a good opportunity, to reach the TP.
The price action is supported with the AI hype, that is e
🏥💼 Boston Scientific (BSX) Investment Analysis 💡📈Strategic Acquisitions:
Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China.
Innovative Product Introductions
BSX - Short IdeaI believe BSX had a good run up the past couple of weeks. And by looking at how its finding resistance at the top key levels, I expect to have a potential move down to $54 area. Again, risk management is key. Expected return vs risk is important. Always keep that in mind. The markets are choppy so y
$BSX Soars to Record Highs: A Compelling Investment Opportunity
With a recent surge to record highs, fueled by positive developments and robust financial performance, here's a compelling case for potential buyers to consider adding NYSE:BSX stock to their portfolios.
1. Technical Analysis: Riding the Rising Trend Channel
Boston Scientific is currently rid
Support ReachedThe high of October has been re-tested today. It serves as support now and is valid the more as is coincides with the 2 38% Fibonacci levels. A correction of the December decline seems to be likely.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.47%
Maturity date
Jan 15, 2040
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.35%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.32%
Maturity date
Mar 1, 2039
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
4.82%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.81%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.66%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.64%
Maturity date
Mar 1, 2026
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.31%
Maturity date
Mar 8, 2034
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
3.20%
Maturity date
Jun 1, 2025
Explore more bonds
Frequently Asked Questions
The current price of BSX is 86.99 USD — it has decreased by −0.69% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Boston Scientific Corporation stocks are traded under the ticker BSX.
BSX stock has fallen by −0.66% compared to the previous week, the month change is a 0.52% rise, over the last year Boston Scientific Corporation has showed a 61.24% increase.
We've gathered analysts' opinions on Boston Scientific Corporation future price: according to them, BSX price has a max estimate of 110.00 USD and a min estimate of 86.00 USD. Watch BSX chart and read a more detailed Boston Scientific Corporation stock forecast: see what analysts think of Boston Scientific Corporation and suggest that you do with its stocks.
BSX stock is 2.08% volatile and has beta coefficient of 0.78. Track Boston Scientific Corporation stock price on the chart and check out the list of the most volatile stocks — is Boston Scientific Corporation there?
Today Boston Scientific Corporation has the market capitalization of 128.21 B, it has increased by 2.64% over the last week.
Yes, you can track Boston Scientific Corporation financials in yearly and quarterly reports right on TradingView.
Boston Scientific Corporation is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.63 USD per share, whereas the estimation was 0.59 USD resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.65 USD per share. See more details about Boston Scientific Corporation earnings.
Boston Scientific Corporation revenue for the last quarter amounts to 4.21 B USD, despite the estimated figure of 4.04 B USD. In the next quarter, revenue is expected to reach 4.40 B USD.
BSX net income for the last quarter is 469.00 M USD, while the quarter before that showed 324.00 M USD of net income which accounts for 44.75% change. Track more Boston Scientific Corporation financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 17, 2024, the company has 48.00 K employees. See our rating of the largest employees — is Boston Scientific Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Boston Scientific Corporation EBITDA is 3.86 B USD, and current EBITDA margin is 23.71%. See more stats in Boston Scientific Corporation financial statements.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boston Scientific Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Boston Scientific Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Boston Scientific Corporation stock shows the buy signal. See more of Boston Scientific Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.